Pisareva Ekaterina, Roch Benoit, Sanchez Cynthia, Pastor Brice, Mirandola Alexia, Diab-Assaf Mona, Mazard Thibault, Prévostel Corinne, Al Amir Dache Zahra, Thierry Alain R
IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Montpellier University, Montpellier, France.
Thoracic Oncology Unit, Arnaud De Villeneuve Hospital, University Hospital of Montpellier, Montpellier, France.
Front Genet. 2023 Apr 20;14:1104732. doi: 10.3389/fgene.2023.1104732. eCollection 2023.
The function, origin and structural features of circulating nuclear DNA (cir-nDNA) and mitochondrial DNA (cir-mtDNA) are poorly known, even though they have been investigated in numerous clinical studies, and are involved in a number of routine clinical applications. Based on our previous report disproving the conventional plasma isolation used for cirDNA analysis, this work enables a direct topological comparison of the circulating structures associated with nuclear DNA and mitochondrial cell-free DNA. We used a Q-PCR and low-pass whole genome sequencing (LP-WGS) combination approach of cir-nDNA and cir-mtDNA, extracted using a procedure that eliminates platelet activation during the plasma isolation process to prevent mitochondria release in the extracellular milieu. Various physical procedures, such as filtration and differential centrifugation, were employed to infer their circulating structures. DSP-S cir-mtDNA mean size profiles distributed on a slightly shorter range than SSP-S. SSP-S detected 40-fold more low-sized cir-mtDNA fragments (<90 bp/nt) and three-fold less long-sized fragments (>200 bp/nt) than DSP-S. The ratio of the fragment number below 90 bp over the fragment number above 200 bp was very homogenous among both DSP-S and SSP-S profiles, being 134-fold lower with DSP-S than with SSP-S. Cir-mtDNA and cir-nDNA DSP-S and SSP-S mean size profiles of healthy individuals ranged in different intervals with periodic sub-peaks only detectable with cir-nDNA. The very low amount of cir-mtDNA fragments of short size observed suggested that most of the cir-mtDNA is poorly fragmented and appearing longer than ∼1,000 bp, the readout limit of this LP-WGS method. Data suggested that cir-nDNA is, among DNA extracted in plasma, associated with ∼8.6% of large structures (apoptotic bodies, large extracellular vesicles (EVs), cell debris…), ∼27.7% in chromatin and small EVs and ∼63.7% mainly in oligo- and mono-nucleosomes. By contrast, cir-mtDNA appeared to be preponderantly (75.7%) associated with extracellular mitochondria, either in its free form or with large EVs; to a lesser extent, it was also associated with other structures: small EVs (∼18.4%), and exosomes or protein complexes (∼5.9%). This is the first study to directly compare the structural features of cir-nDNA and cir-mtDNA. The significant differences revealed between both are due to the DNA topological structure contained in the nucleus (chromatin) and in the mitochondria (plasmid) that determine their biological stability in blood. Although cir-nDNA and cir-mtDNA are principally associated with mono-nucleosomes and cell-free mitochondria, our study highlights the diversity of the circulating structures associated with cell-free DNA. They consequently have different pharmacokinetics as well as physiological functions. Thus, any accurate evaluation of their biological or diagnostic individual properties must relies on appropriate pre-analytics, and optimally on the isolation or enrichment of one category of their cirDNA associated structures.
尽管循环核DNA(cir-nDNA)和线粒体DNA(cir-mtDNA)已在众多临床研究中得到调查,并参与了许多常规临床应用,但其功能、起源和结构特征仍知之甚少。基于我们之前的报告,该报告反驳了用于cirDNA分析的传统血浆分离方法,这项工作能够对与核DNA和线粒体游离DNA相关的循环结构进行直接拓扑比较。我们使用了cir-nDNA和cir-mtDNA的定量聚合酶链反应(Q-PCR)和低通量全基因组测序(LP-WGS)组合方法,提取过程采用了一种可消除血浆分离过程中血小板激活的程序,以防止线粒体释放到细胞外环境中。采用了各种物理方法,如过滤和差速离心,来推断它们的循环结构。DSP-S cir-mtDNA的平均大小分布范围比SSP-S略短。与DSP-S相比,SSP-S检测到的低大小cir-mtDNA片段(<90 bp/nt)多40倍,长大小片段(>200 bp/nt)少三倍。在DSP-S和SSP-S图谱中,90 bp以下片段数与200 bp以上片段数的比值非常均匀,DSP-S比SSP-S低134倍。健康个体的cir-mtDNA和cir-nDNA DSP-S和SSP-S平均大小图谱分布在不同区间,只有cir-nDNA可检测到周期性亚峰。观察到的短大小cir-mtDNA片段数量极少,这表明大多数cir-mtDNA片段化程度低,长度超过约1000 bp,这是该LP-WGS方法的读出极限。数据表明,在血浆中提取的DNA中,cir-nDNA与约8.6%的大结构(凋亡小体、大细胞外囊泡(EVs)、细胞碎片等)相关,与约27.7%的染色质和小EVs相关,约63.7%主要与寡核小体和单核小体相关。相比之下,cir-mtDNA似乎主要(75.7%)与细胞外线粒体相关,无论是游离形式还是与大EVs相关;在较小程度上,它也与其他结构相关:小EVs(约18.4%),以及外泌体或蛋白质复合物(约5.9%)。这是第一项直接比较cir-nDNA和cir-mtDNA结构特征的研究。两者之间揭示的显著差异是由于细胞核(染色质)和线粒体(质粒)中包含的DNA拓扑结构决定了它们在血液中的生物学稳定性。尽管cir-nDNA和cir-mtDNA主要与单核小体和游离线粒体相关,但我们的研究强调了与游离DNA相关的循环结构的多样性。因此,它们具有不同的药代动力学以及生理功能。因此,对其生物学或诊断个体特性的任何准确评估都必须依赖于适当的分析前处理,最好是对其一类cirDNA相关结构进行分离或富集。